Mpm Bioimpact LLC’s Aktis Oncology Inc Position
Does Mpm Bioimpact LLC own Aktis Oncology Inc (AKTS)? Yes — 4.84M shares worth $87M (+6.68% of its 13F portfolio) as of Q1 2026.
Position Value
$87M
Q1 2026
Shares
4.84M
% of Portfolio
+6.68%
Quarters Held
1
currently held
Position History AKTS
Reported value by quarter
| Quarter | Shares | Value | % of Portfolio |
|---|---|---|---|
| Q1 2026 | 4.84M | $87M | +6.68% |
Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Mpm Bioimpact LLC’s full portfolio or all institutional holders of AKTS.